MediWound

MediWound(MDWD)

YAVNE, Israel
Biotechnology
WebsiteLinkedInCareers Page

Focus: Wound & Burn Care

MediWound is a life sciences company focused on Wound & Burn Care.

OncologyWound Care
Funding Stage
PUBLIC
Open Jobs
1

Products & Portfolio (1)

NEXOBRID
anacaulase-bcdb
Peak
TOPICAL ยท GEL
eschar. The specific components responsible for this effect have not been identified.
2022
30

Pipeline & Clinical Trials

Scars assessment & QOL
Scars Formation
N/A
Clinical Trials (1)
NCT01350700Long Term Follow up of Scars Formation and Quality of Life Assessment Study
N/A
Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compare
Burns, Upper Extremity
N/A
Clinical Trials (1)
NCT01800981Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care
N/A
NexoBrid
Thermal Burn
N/A
Clinical Trials (1)
NCT04040660Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
N/A
Phase 1/2
Clinical Trials (1)
NCT05157763A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Phase 1/2
Phase 2
Clinical Trials (1)
NCT02020746Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds
Phase 2
Phase 2
Clinical Trials (1)
NCT01679678A Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of PolyHeal-2 Versus PolyHeal in Once Daily Regimen
Phase 2
Phase 2
Clinical Trials (1)
NCT06690177Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers
Phase 2
Phase 2
Clinical Trials (1)
NCT03588130A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers
Phase 2
DGD
Burn
Phase 2
Clinical Trials (1)
NCT00898521Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns
Phase 2
Phase 2
Clinical Trials (1)
NCT04817228A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers
Phase 2
Phase 3
Clinical Trials (1)
NCT02278718A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
Phase 3
DGD
Burn
Phase 3
Clinical Trials (1)
NCT00324311Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care
Phase 3
Phase 3
Clinical Trials (1)
NCT06568627A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
Phase 3
Phase 3
Clinical Trials (1)
NCT02148705A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns
Phase 3

Open Jobs (1)

Automation & Computerized Systems Lead

Unknown
IT/Automation
2w ago
Interview Prep Quick Facts
Portfolio: 1 approved product, 14 clinical trials
Open Roles: 1 active job
Portfolio Health
Peak1 (100%)
1 total products